International collaboration

The Faculty of Pharmacy actively cooperates in research and development with leading research centres in Europe and worldwide.
We cooperate with the following partners:.

Department of Pharmaceutical Microbiology Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia Study of antifungal activity of polyene antibiotic-functionalized PHA polymers
Department of Pharmaceutical Microbiology Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Tenerife, Spain Silver nanoparticles in the treatment of eye diseases caused by Acanthamoeba
Microbiota Lab Freie Universitat Berlin, Germany Studies on the biological activity of compounds of natural origin
Microbiota Lab National University of Pharmacy in Kharkov, Ukraine Studies on the composition of plant extracts obtained from the leaves of equal species of the genus Vaccinium and Galium
Microbiota Lab University of Medicine and Pharmacy “Grigore T. Popa”, Iasi, Romania Studies on the anti-inflammatory activity of plant extracts using a human neutrophil model
Microbiota Lab Medical University of Vienna, Austria Studies on the anti-inflammatory activity of intestinal metabolites derived from compounds of natural origin
Department of Pharmaceutical Technology and Biotechnology Institute of Food Technology and Biochemistry, Faculty of Agriculture, University of Belgrade, Belgrade, Serbia
Department of Pharmaceutical Biotechnology and Pharmaceutical Technology Tobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao, China
Department of Pharmaceutical Biotechnology and Pharmaceutical Technology Laboratory for Centrosome and Cytoskeleton Biology, Heinrich Heine University Düsseldorf, Germany Studies on the cellular activity of compounds that break down the CPAP-tubilin complex
Department of Pharmaceutical Technology and Biotechnology Assay Development and Screening Platform, Helmholtz Zentrum München, Germany Determination of the inhibitory potency of CPAP-tubulin complex formation by the resulting small-molecule compounds
Department of Drug Technology and Pharmaceutical Biotechnology Institute of Structural Biology, Helmholtz Zentrum München, oraz Chair of Biomolecular NMR Spectroscopy, Bavarian NMR Center, Technical University of Munich, Germany Design and biophysical studies of novel inhibitors of protein junction formation
Department of Medicinal Technology and Pharmaceutical Biotechnology Institute of Medicinal Chemistry, Helmholtz Zentrum München, Germany Design and synthesis of novel protein junction formation inhibitors and protein kinase inhibitors
Department of Drug Technology and Pharmaceutical Biotechnology The Swiss Tropical and Public Health Institute Basel, Switzeralnd Determination of the antiparasitic activity of PEX14-PEX5 inhibitors
Department of Drug Technology and Pharmaceutical Biotechnology Institute of Biochemistry and Pathobiochemistry, Ruhr University, Bochum, Germany Determination of the antiparasitic activity of PEX14-PEX5 inhibitors
Department of Drug Technology and Pharmaceutical Biotechnology School of Physiology, Pharmacology and Neuroscience, University of Bristol, United Kingdom In vitro cardiotoxicity assays of novel anticonvulsant sodium channel blockers
Department of Pharmaceutical Technology and Biotechnology Laboratory of Experimental Cardiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic In vitro cardiotoxicity assays of novel anticonvulsant sodium channel blockers
Department of Pharmaceutical Technology and Biotechnology Epilepsy Therapy Screening Program, National Institutes of Health, Bethesda, USA Determination of in vivo anticonvulsant activity of the obtained compounds
Department of Pharmaceutical Biotechnology and Pharmaceutical Technology Neural Dynamics Laboratory, University of Melbourne, Australia Investigation of fluorinated sodium channel blockers to detect their binding site
Department of Drug Technology and Pharmaceutical Biotechnology Department of Pharmaceutical Sciences, via del Liceo 1, University of Perugia, 06123 Perugia, Italy
Department of Pharmaceutical Technology and Biotechnology Pharmaceutical Technology and Physico-Chemical Department, Universidad de Barcelona, Spain
Department of Pharmaceutical Biology and Biotechnology of Medicinal Plants Department of Pharmacognosy and Chemistry of Natural Products at National & Kapodistrian University of Athens, Faculty of Pharmacy University of Athens, Greece Boraginaceae plant species with medicinal potential - biotechnological, phytochemical and biological studies
Department of Applied Pharmacy Department of Microbiology and Immunology, Temple University, Philadelphia, USA Cancer gene therapy and rAAV vectorology
Department of Applied Pharmacy Faculty of Science & Engineering, University of Wolverhampton, Wolverhampton, UK Cancer gene therapy and rAAV vectorology
Department of Physical Chemistry Laboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France Investigation of the applicability of molecular modelling methods in the analysis of endocrinically active compounds
Department of Physical Chemistry ChristoforidesPhysics Laboratory, Department of Biotechnology, Agricultural University of Athens, Greece Synthesis and physicochemical analysis of cyclodextrin-drug complexes
Department of Physical Chemistry Biomedicine Department, University of Basel. Switzerland Analysis of the feasibility of covalently interacting kinase inhibitors by binding to non-catalytic cysteines at the ATP-binding site
Department of Physical Chemistry Faculty of Chemistry and Pharmacy, Sofia University, Bulgaria Structural studies of metal-organic complexes with potential biological activity
Department of Analytical Chemistry Institute of Chemical Physics, Faculty of Physics, Vilnius University, Vilnus, Lithuania Investigations of chemical structure and physicochemical properties of composite materials, calcium phosphate ceramics and inorganic silicon compounds
Department of Analytical Chemistry L’Université de Reims Champagne-Ardenne, Laboratoire Biomatériaux et Inflammation en site osseux, France In vitro testing of docking biomaterials